GLP-1, GIP and glucagon: the most studied metabolic pathways

The incretins GLP-1 and GIP are intestinal hormones that modulate insulin secretion in response to nutrients. Glucagon, in contrast, mobilizes energy reserves.

Compounds acting simultaneously on several of these receptors make it possible to study the interaction between satiety, energy expenditure and glycemic control within a single experimental model.

This multi-receptor approach has reoriented metabolic research over the past decade, shifting the focus from single-target molecules to combined pharmacological profiles.

All research in this area is preclinical in the context of the compounds we distribute: this is laboratory material, not a therapeutic product.